• 

  March 18, 2025

  CollPlant Biotechnologies Update – Reports Q3 2024 Results, Advances Regenerative Breast Implant Program

  R.D. Solorzano

• 

  March 18, 2025

  Vericel – Poised for Growth with Expanding Indications and Strong Margins

  R.D. Solorzano

• 

  March 7, 2025

  Sernova Biotherapeutics Secures FDA Clearance for Thyroid Cell Pouch IND Application

  R.D. Solorzano

• 

  March 6, 2025

  Trestle Bio Announces Research Collaboration with Humacyte

  R.D. Solorzano

• 

  February 26, 2025

  Xenotransplantation Advances: United Therapuetics and eGensis Companies to Watch

  R.D. Solorzano

• 

  February 18, 2025

  ARMI BioFabUSA A Catalyst for Regenerative Medicine

  R.D. Solorzano

• 

  February 11, 2025

  BioSapien Extends Pre-Series A Round to $7 Million

  R.D. Solorzano

• 

  February 5, 2025

  United Therapeutics Breaks New Ground with FDA-Cleared Xenotransplantation Trial

  R.D. Solorzano

• 

  January 10, 2025

  Aspect Biosystems Secures $115M Series B to Advance Bioprinted Tissue Therapeutics

  R.D. Solorzano

• 

  December 3, 2024

  EpiBone Secures Funding Convertible Note to Drive Global Expansion of Clinical Trials

  R.D. Solorzano